(Q44905262)

English

No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pascale Jolliet

7

object named as

Pascale Jolliet

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1

object named as

Eric Dailly

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

8

object named as

Michel Bourin

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

François Raffi

9

object named as

François Raffi

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Eric Billaud

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Véronique Reliquet

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sébastien Breurec

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Philippe Perré

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sophie Léautez

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

20 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

343-348

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

https://scigraph.springernature.com/pub.10.1007/s00228-004-0769-5

0 references

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short communication: interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome--a population pharmacokinetic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver toxicity caused by nevirapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-li

1 reference

https://pubmed.ncbi.nlm.nih.gov/15156302

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-004-0769-5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44905262&oldid=2056655623"